Medicine Today CME webcast

Medicine Today
Internal Medicine Webcast Series

Should Diabetes Drugs Require CV
Safety Studies Prior to Approval?

Print this Content

 

 

How to Obtain AMA PRA
Category 1 Credit

  1. Watch the activity on your computer or mobile device.
  2. Complete the CME posttest (each question must be answered correctly).
  3. Login to your account.
  4. Complete the credit and evaluation form.
  5. Print your personalized CME certificate.

Technical Requirements

 

Estimated Time of Completion: 15 minutes

Release Date: November 16, 2011
Expiration Date: November 16, 2013

Description

The Medicine Today, Internal Medicine Webcast Series features CME-certified educational webcasts. Each activity consists of a video presentation up to an hour in length, and related questions following the video.

This internal medicine lecture from the 2011 Diabetes and the Heart Symposium discusses the cardiovascular safety implications to consider when forming clinical trials designed to garner FDA approval of new hypoglycemic agents. This lecture is offered for both traditional personal computers, and mobile devices (smart phones, tablets, iPads, and similar mobile devices).

Learning Objectives

In clinical trials designed to garner FDA approval of new oral hypoglycemic agents:

  1. Describe the history of selection of meaningful endpoints.
  2. Discuss the disconnect sometimes observed between measures of glycemic control and cardiovascular events.
  3. Summarize the public health implications of failure to include cardiovascular end points in addition to measures of glycemic control.

Target Audience

This activity is directed to physicians, general internists, family practitioners, endocrinologists and cardiovascular subspecialists as well as all other medical professionals who manage diabetes patients with cardiovascular disease risks.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Activity Director

William D. Carey, MD
Director, Center for Continuing Education
Cleveland Clinic
Cleveland, Ohio

Faculty

Steven E. Nissen, MD, MACC
Chairman, Robert Tomsich Department of Cardiovascular Medicine
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Director, Joseph J. Jacobs Center of Thrombosis and Vascular Biology
Heart and Vascular Institute
Cleveland Clinic
Cleveland, Ohio

Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated they have no relationship which, in the context of their contribution, could be perceived as a potential conflict of interest:

William D. Carey, MD
Steven E. Nissen, MD, MACC

 

*Mobile devices include smart phones, tablets and iOS devices (iPhone, iPod Touch, iPad).

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education.

CME Disclaimer